Format

Send to

Choose Destination
See comment in PubMed Commons below
J Am Coll Cardiol. 2013 Nov 5;62(19):1737-45. doi: 10.1016/j.jacc.2013.05.076. Epub 2013 Jul 17.

Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.

Author information

1
Department of Cardiology and Pneumology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Institute for Chemistry-Biochemistry, Freie Universität Berlin, Berlin, Germany.

Abstract

OBJECTIVES:

This study sought to evaluate the role of protease-activated receptor-2 (PAR2) in coxsackievirus B3 (CVB3)-induced myocarditis.

BACKGROUND:

An infection with CVB3 leads to myocarditis. PAR2 modulates the innate immune response. Toll-like receptor-3 (TLR3) is crucial for the innate immune response by inducing the expression of the antiviral cytokine interferon-beta (IFNβ).

METHODS:

To induce myocarditis, wild-type (wt) and PAR2 knockout (ko) mice were infected with 10(5) plaque-forming units CVB3. Mice underwent hemodynamic measurements with a 1.2-F microconductance catheter. Wt and PAR2ko hearts and cardiac cells were analyzed for viral replication and immune response with plaque assay, quantitative polymerase chain reaction, Western blot, and immunohistochemistry.

RESULTS:

Compared with wt mice, PAR2ko mice and cardiomyocytes exhibited a reduced viral load and developed no myocarditis after infection with CVB3. Hearts and cardiac fibroblasts from PAR2ko mice expressed higher basal levels of IFNβ than wt mice did. Treatment with CVB3 and polyinosinic:polycytidylic acid led to higher IFNβ expression in PAR2ko than in wt fibroblasts and reduced virus replication in PAR2ko fibroblasts was abrogated by neutralizing IFNβ antibody. Overexpression of PAR2 reduced the basal IFNβ expression. Moreover, a direct interaction between PAR2 and Toll-like receptor 3 was observed. PAR2 expression in endomyocardial biopsies of patients with nonischemic cardiomyopathy was positively correlated with myocardial inflammation and negatively with IFNβ expression and left ventricular ejection fraction.

CONCLUSIONS:

PAR2 negatively regulates the innate immune response to CVB3 infection and contributes to myocardial dysfunction. The antagonism of PAR2 is of therapeutic interest to strengthen the antiviral response after an infection with a cardiotropic virus.

KEYWORDS:

AP; CAR; CCL; CD; CVB3; DAF; DMEM; Dulbecco modified Eagle medium; FBS; HL; IFNβ; IFNγ; IL; LVEF; P-Stat1; PAR2; PBS; PCR; TLR; TNFα; Toll-like receptor; Toll-like receptor 3; activating peptide; chemokine ligand; cluster of differentiation; coxsackievirus B3; coxsackievirus-adenovirus receptor; decay-accelerating receptor; double-stranded ribonucleic acid; dsRNA; fetal bovine serum; human leukocyte; interferon beta; interferon gamma; interferon-beta; interleukin; knockout; ko; left ventricular ejection fraction; mRNA; messenger ribonucleic acid; mock plasmid; myocarditis; p.i.; pVitro; phosphate-buffered saline; phospho-signal transducer and activator of transcription-1; poly(I:C); polyinosinic: polycytidylic acid; polymerase chain reaction; post-infection; protease-activated receptor 2; protease-activated receptor-2; tumor necrosis factor-alpha; wild type; wt

Comment in

PMID:
23871888
PMCID:
PMC4077621
DOI:
10.1016/j.jacc.2013.05.076
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center